Table 2.
Variable | Value | Number of subjects (%) |
---|---|---|
Age | Mean (SD) | 55.5 (11.2) |
Median (range) | 58 (18–79) | |
Gender | Female | 784 (40.0%) |
Male | 1175 (60.0%) | |
Geographic region of residence | North central | 573 (29.2%) |
Northeast | 304 (15.5%) | |
West | 328 (16.7%) | |
South | 743 (37.9%) | |
Unknown | 11 (0.6%) | |
Health plan typea | HMO | 307 (15.7%) |
EPO/PPO | 1094 (55.8%) | |
POS | 177 (9.0%) | |
Comprehensive | 210 (10.7%) | |
HDHP/CDHP | 151 (7.7%) | |
Unknown | 20 (1.0%) | |
Comorbidities | Chronic pulmonary disease | 487 (24.9%) |
Renal disease | 427 (21.8%) | |
Diabetes | 345 (17.6%) | |
Liver disease | 201 (10.3%) | |
Peripheral vascular disease | 145 (7.4%) | |
Asthma | 130 (6.6%) | |
Congestive heart failure | 125 (6.4%) | |
Cerebrovascular disease | 99 (5.1%) | |
History of myocardial infarction | 63 (3.2%) | |
Rheumatologic disease | 43 (2.2%) | |
Peptic ulcer disease | 34 (1.7%) | |
Hemiplegia or paraplegia | 18 (0.9%) | |
HIV/AIDS | 9 (0.5%) | |
Dementia | 3 (0.2%) |
a HMO health maintenance organization, EPO exclusive provider organization, PPO preferred provider organization, POS point of service, HDHP high-deductible health plan, CDHP consumer-driven health plan